CD25 Blockade Delays Regulatory T Cell Reconstitution and Does Not Prevent Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation-Reference-Cited by-同舟云学术

CD25 Blockade Delays Regulatory T Cell Reconstitution and Does Not Prevent Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation

Published:2017-03 Issue:3 Volume:23 Page:405-411
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Locke Frederick L.,Pidala Joseph,Storer Barry,Martin Paul J.,Pulsipher Michael A.,Chauncey Thomas R.,Jacobsen Niels,Kröger Nicolaus,Walker Irwin,Light Susan,Shaw Bronwen E.,Beato Francisca,Laport Ginna G.,Nademanee Auayporn,Keating Armand,Socie Gerard,Anasetti Claudio

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference46 articles.

1. Effect of up-front daclizumab when combined with steroids for the treatment of acute graft-versus-host disease: results of a randomized trial;Lee;Blood,2004

2. Daclizumab, a humanized anti-interleukin-2 receptor alpha chain antibody, for treatment of acute graft-versus-host disease;Przepiorka;Blood,2000

3. Treatment of steroid-refractory acute and chronic graft-versus-host disease with daclizumab;Willenbacher;Br J Haematol,2001

4. Improved survival in steroid-refractory acute graft versus host disease after non-myeloablative allogeneic transplantation using a daclizumab-based strategy with comprehensive infection prophylaxis;Srinivasan;Br J Haematol,2004

5. Treatment of steroid-resistant acute graft-versus-host disease with daclizumab and etanercept;Wolff;Bone Marrow Transplant,2005

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modeling the interaction between donor-derived regulatory T cells and effector T cells early after allogeneic hematopoietic stem cell transplantation;Biosystems;2023-05

2. Lower dose of ATG combined with basiliximab for haploidentical hematopoietic stem cell transplantation is associated with effective control of GVHD and less CMV viremia;Frontiers in Immunology;2022-11-15

3. Harnessing Treg Homeostasis to Optimize Posttransplant Immunity: Current Concepts and Future Perspectives;Frontiers in Immunology;2021-08-30

4. GVHD Pathogenesis, Prevention and Treatment: Lessons From Humanized Mouse Transplant Models;Frontiers in Immunology;2021-07-29

5. Immunomodulatory Therapies for the Treatment of Graft-versus-host Disease;HemaSphere;2021-06